Investment
Features
FeesSafety
Academy
More
Pluang+

Class action lawsuit filed against iTonic Holdings for alleged pump-and-dump scheme crashing shares 95%.

Market News
31 Jul 2026
Newsfile Corp
View Source
Bearish
pluang ai news

A class action lawsuit has been filed against iTonic Holdings Ltd (formerly Pheton Holdings Ltd) accusing its officers, auditor, and IPO underwriters of orchestrating a pump-and-dump scheme. The lawsuit alleges that promoters spread false rumors, including a fake acquisition by Gilead Sciences, to inflate the stock price, which then collapsed by about 95% in one day on July 29, 2025. Investors who bought shares between September 2024 and July 2025 can seek lead plaintiff status by September 29, 2026. The case is ongoing in the Southern District of New York, with Morris Kandinov LLP representing the plaintiffs.

More News

Scotiabank raises Palo Alto Networks price target to $430 after strong Q3 and growth outlook.

Scotiabank raises Palo Alto Networks price target to $430 after strong Q3 and growth outlook.

Scotiabank increased its price target for Palo Alto Networks to $430, suggesting a 13% upside from current levels, following a 30% surge in shares after strong Q3 results. The cybersecurity firm is expected to deliver robust Q4 performance and signif...

Analyst Insights
Bullish
1 hour ago
Fiserv stock downgraded amid lowered 2026 growth and profit forecasts, with shares expected to drop nearly 17%.

Fiserv stock downgraded amid lowered 2026 growth and profit forecasts, with shares expected to drop nearly 17%.

Fiserv faces a downgrade from Cantor Fitzgerald with a new price target of $53, down nearly 17% from its recent price of $63.80. The company cut its 2026 guidance, expecting flat to slightly negative organic growth and a 14.2% drop in earnings per sh...

Analyst Insights
Bearish
2 hours ago
BioMarin Pharma gains with analyst upgrade, patent deal, and $275M acquisition boosting growth.

BioMarin Pharma gains with analyst upgrade, patent deal, and $275M acquisition boosting growth.

BioMarin Pharmaceutical Inc. saw its stock gain momentum after Jefferies raised its price target to $105, signaling strong confidence in the biotech firm. The company secured new revenue streams through a patent settlement with Ascendis Pharma, earni...

Analyst Insights
Bullish
3 hours ago
Aehr Test Systems CEO sells $5.2M shares after stock price jumps 564%.

Aehr Test Systems CEO sells $5.2M shares after stock price jumps 564%.

Aehr Test Systems' CEO sold shares worth $5.2 million following a remarkable 564% increase in the company's stock price. This significant sale highlights the CEO capitalizing on the stock's strong rally. Investors may view this move as a signal about...

Market News
Neutral
3 hours ago
Zoomd Technologies beats EPS estimates with 11% revenue growth and strong financial health.

Zoomd Technologies beats EPS estimates with 11% revenue growth and strong financial health.

Zoomd Technologies Ltd. reported a second-quarter EPS of $0.01, surpassing analyst estimates of $0.0038, signaling better-than-expected profitability. Although quarterly revenue was $7.67 million, slightly below the $8.41 million forecast, the compan...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App